A Study to Evaluate the Safety, Tolerability and PK of SK-08

Clinical trial NCT07021157 · RECRUITING

Trial details

NCT number: NCT07021157
Sponsor: Consun Pharmaceutical Group
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease(CKD)

Start date: 2025-03-09
Primary completion: 2025-08-07
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.